{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:35:20Z","timestamp":1793306120851,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012679","name":"Institut de Cardiologie de Montr\u00e9al","doi-asserted-by":"publisher","award":["2020\\u20131-UK01-KA107\\u2013078782"],"award-info":[{"award-number":["2020\\u20131-UK01-KA107\\u2013078782"]}],"id":[{"id":"10.13039\/501100012679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/14\/49\/30838"],"award-info":[{"award-number":["FS\/14\/49\/30838"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/4yPhD\/F\/20\/34127A"],"award-info":[{"award-number":["FS\/4yPhD\/F\/20\/34127A"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["PG\/19\/84\/34771"],"award-info":[{"award-number":["PG\/19\/84\/34771"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["RE\/18\/5\/34216"],"award-info":[{"award-number":["RE\/18\/5\/34216"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["FS\/19\/56\/34893A"],"award-info":[{"award-number":["FS\/19\/56\/34893A"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["PG\/21\/10634"],"award-info":[{"award-number":["PG\/21\/10634"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["PG\/21\/10541"],"award-info":[{"award-number":["PG\/21\/10541"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","award":["PG\/21\/10557"],"award-info":[{"award-number":["PG\/21\/10557"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20203YAY9B"],"award-info":[{"award-number":["20203YAY9B"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017NKB2N4_003"],"award-info":[{"award-number":["2017NKB2N4_003"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-CoG- 726318"],"award-info":[{"award-number":["ERC-CoG- 726318"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.phrs.2023.107050","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T21:50:32Z","timestamp":1703800232000},"page":"107050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"200","author":[{"given":"Elisabetta","family":"Caiazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma O.M.","family":"Rezig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa I.","family":"Morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Czesnikiewicz-Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ialenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sulicka-Grodzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone H.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.107050_bib1","unstructured":"Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37\u201355."},{"key":"10.1016\/j.phrs.2023.107050_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","article-title":"Inflammation and cardiovascular diseases: lessons from seminal clinical trials","volume":"117","author":"Liberale","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib3","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/cvr\/cvac053","article-title":"Long-term trends in the epidemiology of cardiovascular diseases in the uk: insights from the british heart foundation statistical compendium","volume":"118","author":"Cheema","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-017-0537-6","article-title":"Novel immune mechanisms in hypertension and cardiovascular risk","volume":"11","author":"Nosalski","year":"2017","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"10.1016\/j.phrs.2023.107050_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","article-title":"Endothelial dysfunction and hypertension","volume":"64","author":"Brandes","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib7","first-page":"2589","article-title":"Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective","volume":"117","author":"Murray","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/CIRCULATIONAHA.119.045102","article-title":"White blood cells and blood pressure: a mendelian randomization study","volume":"141","author":"Siedlinski","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.107050_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107799","article-title":"Role of inflammatory chemokines in hypertension","volume":"223","author":"Mikolajczyk","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2023.107050_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-2143(97)90178-5","article-title":"Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?","volume":"129","author":"Dalekos","year":"1997","journal-title":"J. Lab Clin. Med."},{"key":"10.1016\/j.phrs.2023.107050_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ajh.2011.113","article-title":"Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans","volume":"24","author":"Chamarthi","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib14","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1152\/ajpregu.00466.2007","article-title":"Tnf-alpha inhibition reduces renal injury in doca-salt hypertensive rats","volume":"294","author":"Elmarakby","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2023.107050_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin ii-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI76327","article-title":"Lymphocyte adaptor protein lnk deficiency exacerbates hypertension and end-organ inflammation","volume":"125","author":"Saleh","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2023.107050_bib17","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/HYPERTENSIONAHA.109.146902","article-title":"Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension","volume":"55","author":"Crosswhite","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib18","doi-asserted-by":"crossref","first-page":"H935","DOI":"10.1152\/ajpheart.00708.2005","article-title":"Angiotensin ii hypertension is attenuated in interleukin-6 knockout mice","volume":"290","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.107050_bib19","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/cvr\/cvab321","article-title":"Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin ii infused mice through increased oxidative stress","volume":"118","author":"Gonzalez-Amor","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biopha.2018.05.118","article-title":"Effect of infliximab and tocilizumab on fructose-induced hyperinsulinemia and hypertension in rats","volume":"105","author":"Abdelrahman","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2023.107050_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.36660\/abc.202190703","article-title":"Effects of anti-tnf alpha therapy on blood pressure in resistant hypertensive subjects: a randomized, double-blind, placebo-controlled pilot study","volume":"116","author":"Faria","year":"2021","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.phrs.2023.107050_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of interleukin-1beta inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of cantos","volume":"75","author":"Rothman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130709","article-title":"The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: a 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab","volume":"10","author":"Provan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.107050_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/cyto.1995.0071","article-title":"Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells","volume":"7","author":"Schindler","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2023.107050_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2567.1998.00524.x","article-title":"The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production","volume":"94","author":"Peeters","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2023.107050_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.jhh.1001845","article-title":"Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects","volume":"19","author":"Vazquez-Oliva","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib27","doi-asserted-by":"crossref","first-page":"R916","DOI":"10.1152\/ajpregu.00406.2002","article-title":"Cardiovascular and renal sympathetic activation by blood-borne tnf-alpha in rat: the role of central prostaglandins","volume":"284","author":"Zhang","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2023.107050_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.34.1.118","article-title":"Induction of interleukin-6 expression by angiotensin ii in rat vascular smooth muscle cells","volume":"34","author":"Funakoshi","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.RES.84.6.695","article-title":"Angiotensin ii induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa b transcription factors","volume":"84","author":"Han","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib30","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin ii regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.phrs.2023.107050_bib31","doi-asserted-by":"crossref","first-page":"H111","DOI":"10.1152\/ajpheart.01061.2003","article-title":"Effect of at1 receptor antagonism on vascular and circulating inflammatory mediators in shr: role of nf-kappab\/ikappab system","volume":"288","author":"Sanz-Rosa","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.107050_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.107050_bib33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2023.107050_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106053","article-title":"Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with covid-19, sars, mers or influenza: a systematic review and meta-analysis of randomised trials","volume":"176","author":"Caiazzo","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2023.107050_bib36","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","article-title":"From rescue to zeus: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?","volume":"117","author":"Ridker","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","article-title":"Independent association between inflammatory markers (c-reactive protein, interleukin-6, and tnf-alpha) and essential hypertension","volume":"19","author":"Bautista","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajh\/hpz132","article-title":"Role of inflammatory biomarkers in the prevalence and incidence of hypertension among hiv-positive participants in the start trial","volume":"33","author":"Ghazi","year":"2020","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jhh.2010.91","article-title":"The relationship between inflammation, obesity and risk for hypertension in the multi-ethnic study of atherosclerosis (mesa)","volume":"25","author":"Lakoski","year":"2011","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/01.HYP.0000252664.24294.ff","article-title":"Comparison of interleukin-6 and c-reactive protein for the risk of developing hypertension in women","volume":"49","author":"Sesso","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001802","article-title":"Plasma inflammatory markers and the risk of developing hypertension in men","volume":"4","author":"Sesso","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.107050_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2010.156794","article-title":"Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women","volume":"57","author":"Wang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phrs.2023.107050_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100067","article-title":"Inflammation and hypertension development: a longitudinal analysis of the african-predict study","volume":"7","author":"Crouch","year":"2020","journal-title":"Int. J. Cardiol. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/2047487318822354","article-title":"The african prospective study on the early detection and identification of cardiovascular disease and hypertension (african-predict): design, recruitment and initial examination","volume":"26","author":"Schutte","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.phrs.2023.107050_bib45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ajh\/hpx053","article-title":"Elevated plasma transforming growth factor beta1 levels predict the development of hypertension in normotensives: the 14-year follow-up study","volume":"30","author":"Nakao","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib46","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ahj.2010.03.023","article-title":"Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus","volume":"159","author":"Sahakyan","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2023.107050_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41371-020-00422-2","article-title":"The association between serum inflammatory biomarkers and incident hypertension among postmenopausal women in the buffalo osteoperio study","volume":"35","author":"Gordon","year":"2021","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ajh.2011.141","article-title":"Relationship of plasma interleukin-6 and its genetic variants with hypertension in hong kong chinese","volume":"24","author":"Cheung","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib49","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5272","article-title":"Hypertension in relation to dioxins and polychlorinated biphenyls from the anniston community health survey follow-up","volume":"127","author":"Pavuk","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.phrs.2023.107050_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5693271","article-title":"Elevated lipoprotein-associated phospholipase a(2) independently affects age-related increases in systolic blood pressure: a nested case-control study in a prospective korean cohort","volume":"2020","author":"Yoo","year":"2020","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/619704","article-title":"Proinflammation and hypertension: a population-based study","volume":"2008","author":"Mauno","year":"2008","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2023.107050_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO;2-Q","article-title":"The biological effects of interleukin 6","volume":"16","author":"Barton","year":"1996","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2023.107050_bib53","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1161\/ATVBAHA.107.153080","article-title":"Il-6 deficiency protects against angiotensin ii induced endothelial dysfunction and hypertrophy","volume":"27","author":"Schrader","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.107050_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphys.2014.00396","article-title":"Angiotensin ii-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation","volume":"5","author":"Gomolak","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2023.107050_bib55","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/heartjnl-2018-314216","article-title":"Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies","volume":"105","author":"Jayedi","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2023.107050_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081011","article-title":"Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in japanese and american subjects","volume":"10","author":"Kuwabara","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.107050_bib57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib58","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/cvr\/cvab357","article-title":"Contributions of obesity to kidney health and disease: insights from mendelian randomization and the human kidney transcriptomics","volume":"118","author":"Xu","year":"2022","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2023.107050_bib59","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jcem.85.3.6355","article-title":"Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study","volume":"85","author":"Straub","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.107050_bib60","first-page":"126","article-title":"Circulating il-6, clusterin and irisin in obese subjects with different grades of obesity: association with insulin resistance and sexual dimorphism","volume":"65","author":"Werida","year":"2021","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.107050_bib61","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.107050_bib62","article-title":"Inflammatory cytokines in general and central obesity and modulating effects of physical activity","volume":"10","author":"Schmidt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.107050_bib63","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/cvr\/cvab171","article-title":"Central role of c-src in nox5- mediated redox signalling in vascular smooth muscle cells in human hypertension","volume":"118","author":"Camargo","year":"2022","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2023.107050_bib64","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/cvr\/cvab264","article-title":"Risk factors profile of young and older patients with myocardial infarction","volume":"118","author":"Sagris","year":"2022","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2023.107050_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2023.107050_bib66","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-200307000-00028","article-title":"Hypertension among hiv patients: prevalence and relationships to insulin resistance and metabolic syndrome","volume":"21","author":"Gazzaruso","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0125-2","article-title":"Hypertension, kidney disease, hiv and antiretroviral therapy among tanzanian adults: a cross-sectional study","volume":"12","author":"Peck","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.phrs.2023.107050_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","article-title":"Global prevalence of hypertension among people living with hiv: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jhh.2015.97","article-title":"Evidence of increased blood pressure and hypertension risk among people living with hiv on antiretroviral therapy: a systematic review with meta-analysis","volume":"30","author":"Nduka","year":"2016","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1310\/hct1102-100","article-title":"Aging and hiv infection: a comparison between older hiv-infected persons and the general population","volume":"11","author":"Onen","year":"2010","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.phrs.2023.107050_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","article-title":"Hypertension in hiv-infected adults: Novel pathophysiologic mechanisms","volume":"72","author":"Fahme","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.107050_bib72","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/HJH.0000000000001723","article-title":"Blood pressure and mortality in a prospective cohort of hiv-infected adults in port-au-prince, haiti","volume":"36","author":"Batavia","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2023.107050_bib73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000001074","article-title":"D-dimer levels and traditional risk factors are associated with incident hypertension among hiv-infected individuals initiating antiretroviral therapy in uganda","volume":"73","author":"Okello","year":"2016","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.phrs.2023.107050_bib74","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijcard.2015.03.041","article-title":"Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population","volume":"184","author":"Botha","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2023.107050_bib75","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cvr\/cvaa202","article-title":"Interleukin-7 and interleukin-15 drive cd4+cd28null t lymphocyte expansion and function in patients with acute coronary syndrome","volume":"117","author":"Bullenkamp","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Alexander","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib77","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/bph.13818","article-title":"Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?","volume":"174","author":"Welsh","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.107050_bib78","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/cvr\/cvac133","article-title":"Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions","volume":"118","author":"Pugliese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib79","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/cvr\/cvac114","article-title":"From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021\/22","volume":"118","author":"Evans","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.107050_bib80","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/cvr\/cvab337","article-title":"Interleukin-1beta suppression dampens inflammatory leucocyte production and uptake in atherosclerosis","volume":"118","author":"Hettwer","year":"2022","journal-title":"Cardiovasc. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823004061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823004061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:35:55Z","timestamp":1778582155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823004061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":80,"alternative-id":["S1043661823004061"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.107050","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.107050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107050"}}